Guilin Sanjin Pharmaceutical Co Ltd (002275) — Cash Flow-to-Debt Ratio
Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of CN¥117.62 Million could theoretically repay 0% of its total liabilities (CN¥1.05 Billion) in one year. See 002275 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guilin Sanjin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Guilin Sanjin Pharmaceutical Co Ltd across 19 annual periods. Also explore Guilin Sanjin Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Year-by-year debt coverage analysis for Guilin Sanjin Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 002275 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | CN¥588.33 Million | CN¥1.22 Billion | ▼ -1.9% |
| 2023 | 0.49x | CN¥549.25 Million | CN¥1.12 Billion | ▲ +6.9% |
| 2022 | 0.46x | CN¥528.67 Million | CN¥1.15 Billion | ▲ +40.6% |
| 2021 | 0.33x | CN¥410.24 Million | CN¥1.26 Billion | ▼ -49.6% |
| 2020 | 0.65x | CN¥597.99 Million | CN¥923.27 Million | ▼ -17.0% |
| 2019 | 0.78x | CN¥468.29 Million | CN¥600.18 Million | ▼ -15.2% |
| 2018 | 0.92x | CN¥551.73 Million | CN¥599.47 Million | ▲ +36.6% |
| 2017 | 0.67x | CN¥387.82 Million | CN¥575.65 Million | ▼ -44.2% |
| 2016 | 1.21x | CN¥536.85 Million | CN¥444.26 Million | ▲ +26.3% |
| 2015 | 0.96x | CN¥398.50 Million | CN¥416.59 Million | ▲ +11.7% |
| 2014 | 0.86x | CN¥396.53 Million | CN¥463.07 Million | ▲ +32.5% |
| 2013 | 0.65x | CN¥314.16 Million | CN¥486.11 Million | ▼ -13.0% |
| 2012 | 0.74x | CN¥302.59 Million | CN¥407.26 Million | ▼ -52.5% |
| 2011 | 1.56x | CN¥341.05 Million | CN¥218.18 Million | ▼ -0.6% |
| 2010 | 1.57x | CN¥285.49 Million | CN¥181.47 Million | ▲ +20.8% |
| 2009 | 1.30x | CN¥363.29 Million | CN¥279.00 Million | ▲ +158.2% |
| 2008 | 0.50x | CN¥190.97 Million | CN¥378.65 Million | ▲ +7.2% |
| 2007 | 0.47x | CN¥164.39 Million | CN¥349.58 Million | ▼ -55.8% |
| 2006 | 1.06x | CN¥217.67 Million | CN¥204.48 Million | — |